2022 Biogen Half-Year Review and Outlook-Strategic SWOT Analysis, Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Industry
This report is part of the LeadingMarketResearch.com Competitive Analysis Series, which includes assessments of more than 1,000 companies worldwide.
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
The report provides significant competitor information, analysis and insight critical to the development and implementation of effective marketing and R&D programs, including:
- Latest organizational and management developments
- Acquisitions and divestitures
- Marketing tactics
- Financial results
- Strengths and weaknesses
- Strategic directions
- To help current suppliers realistically assess their financial, technological and marketing capabilities vis-?-vis their major competitors.
- To assist potential market entrants in evaluating prospective acquisitions and joint venture candidates.
- To complement the organizations’ internal competitor information gathering efforts with objective analysis, data interpretation and insight.
More Publications
Bristol-Myers Squibb: Performance, Capabilities, Goals and Strategies in the Worldwide Pharmaceutical Market
US$ 1,520.00
August 2011
88 pages
Vertex Pharmaceuticals: Performance, Capabilities, Goals and Strategies in the Global Pharmaceutical Market, 2019
US$ 750.00
May 2019
-
2020 Cronos Group Performance, Capabilities, Goals and Strategies
US$ 950.00
March 2020
-
2019 Pharmaceutical Competitive Intelligence: Bayer Performance, Capabilities, Goals and Strategies
US$ 950.00
February 2019
-
2021 Endo Pharmaceuticals SWOT Analysis-Performance, Capabilities, Goals and Strategies
US$ 750.00
January 2021
-
